v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (236,084) $ (66,092)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 16,771 8,679
Change in fair value on directors' deferred share units ("DDSU") 6,243 152
Change in fair value of 2022 USD Financing Warrants 106,277 (4,771)
Accretion of discount on investments, net (773) (2,422)
Unrealized foreign exchange (11) 1
Other non-cash adjustments 436 (193)
Changes in operating assets and liabilities:    
Prepaid and other current assets 321 1,736
Other noncurrent assets (15) 2
Accounts payable 1,618 2,206
Accrued expenses 9,847 1,679
Other liabilities, long-term (39) 5
Net cash used in operating activities (95,409) (59,018)
Cash flows from investing activities    
Purchases of investments (355,738) (235,746)
Maturity of investments 81,000 33,750
Net cash used in investing activities (274,738) (201,996)
Cash flows from financing activities    
Proceeds from equity offerings 805,000 0
Payment of equity offering costs (46,418) 0
Proceeds from credit facility 0 42,000
Repayment of credit facility 0 (22,000)
Payment of credit facility issuance costs 0 (447)
Proceeds from exercise of pre-funded warrants 9 0
Proceeds from exercise of 2022 USD Financing Warrants 6,652 579
Proceeds from exercise of options 2,056 334
Proceeds from issuance of common shares under ESPP 276 186
Net cash provided by financing activities 767,575 20,652
Effect of exchange rate changes on cash 2 13
Net increase/(decrease) in cash and cash equivalents 397,430 (240,349)
Cash and cash equivalents, beginning of period 257,837 273,741
Cash and cash equivalents, end of period 655,267 33,392
Supplemental Cash Flow Information    
Cash paid for interest and final payment for credit facility 2,122 3,187
Supplemental Noncash Disclosures    
Conversion of 2022 USD Financing Warrants to common shares upon exercise of warrants 34,165 295
Issuance of common shares upon conversion of term loan principal 4,500 0
Equity offering costs in prepaids and other current assets, net 148 0
Lease liabilities arising from obtaining right-of-use assets 135 586
Amortization of deferred financing costs 82 0
Proceeds from exercise of 2022 USD Financing Warrants in prepaid and other current assets 28 0
Withholding taxes payable on option exercises $ 0 $ 17